|
|
|||
|
|||
|
|
|||
|
radu albala |
|||
|
|
|||
|
|||
![]()
|
|||
|
|
|||
|
radu albala Manufacturer: Allergan (naphazoline hydrochloride ophthalmic solution, USP) 0.1% Sterile
Chemical Name: 2-(1-Naphthylmethyl)-2-imidazoline monohydrochloride Contains: Active: naphazoline HCl 0.1% radu albala. Preservative: benzalkonium chloride 0.004% radu albala. Inactives: citric acid, monohydrate; edetate disodium; polyvinyl alcohol 1.4%;purified water; sodium chloride; sodium citrate, dihydrate; and sodium hydroxideto adjust the pH radu albala. It has a shelf life pH range of 5.5 to 6.5 radu albala.
General: Use with caution in the presence of hypertension, cardiovascular abnormalities,hyperglycemia (diabetes), hyperthyroidism, infection or injury radu albala. Patient Information: Patients should be advised to discontinue the drug andconsult a physician if relief is not obtained within 48 hours of therapy, ifirritation, blurring or redness persists or increases, or if symptoms of systemicabsorption occur, i.e., dizziness, headache, nausea, decrease in body temperature,or drowsiness radu albala. To prevent contaminating the dropper tip and solution, do not touch the eyelidsor the surrounding area with the dropper tip of the bottle radu albala. If solution changescolor or becomes cloudy, do not use radu albala.
Pregnancy: Pregnancy Category C: Animal reproduction studies have not beenconducted with naphazoline radu albala. It is also not known whether naphazoline can causefetal harm when administered to a pregnant woman or can affect reproductioncapacity radu albala. Naphazoline should be given to a pregnant woman only if clearly needed radu albala. Nursing Mothers: It is not known whether naphazoline is excreted in human milk radu albala. Because many drugs are excreted in human milk, caution should be exercised whennaphazoline is administered to a nursing woman radu albala. Pediatric Use: Safety and effectiveness in pediatric patients have not beenestablished radu albala. See " Warnings " AND " Contraindications ."
Ocular: Mydriasis, increased redness, irritation, discomfort, blurring, punctatekeratitis, lacrimation, increased intraocular pressure radu albala. Systemic: Dizziness, headache, nausea, sweating, nervousness, drowsiness, weakness,hypertension, cardiac irregularities, and hyperglycemia radu albala.
15 mL in 15 mL bottle - NDC 11980-154-15 Note: Store between 15° to 25°C (59° to 77°F) radu albala. Rx only |
|||
![]()
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
| rradu albala raadu albala raddu albala raduu albala radu albala radu aalbala radu allbala radu albbala radu albaala radu alballa radu albalaa adu albala rdu albala rau albala rad albala radualbala radu lbala radu abala radu alala radu albla radu albaa radu albal r adu albala ra du albala rad u albala radu albala radu albala radu a lbala radu al bala radu alb ala radu alba la radu albal a radu albala ardu albala rdau albala raud albala rad ualbala radua lbala radu labala radu ablala radu alabla radu alblaa radu albaal aradu albala theradu albala radu albala | |||
|
|
|||
|
|
|||
|
|
|||
|
Copyright 2005 D-S LTD. |